US2167480A
(en)
|
1927-11-02 |
1939-07-25 |
Rca Corp |
Signaling
|
US4703004A
(en)
|
1984-01-24 |
1987-10-27 |
Immunex Corporation |
Synthesis of protein with an identification peptide
|
JPS6440808A
(en)
|
1987-08-05 |
1989-02-13 |
Canon Kk |
Zoom lens
|
US6214804B1
(en)
|
1989-03-21 |
2001-04-10 |
Vical Incorporated |
Induction of a protective immune response in a mammal by injecting a DNA sequence
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
US5264618A
(en)
|
1990-04-19 |
1993-11-23 |
Vical, Inc. |
Cationic lipids for intracellular delivery of biologically active molecules
|
US6183745B1
(en)
|
1990-12-12 |
2001-02-06 |
The University Of Queensland |
Subunit papilloma virus vaccine and peptides for use therein
|
CA2115364A1
(en)
|
1991-08-16 |
1993-03-04 |
Philip L. Felgner |
Composition and method for treating cystic fibrosis
|
US6419931B1
(en)
*
|
1991-08-26 |
2002-07-16 |
Epimmune Inc. |
Compositions and methods for eliciting CTL immunity
|
IL102964A0
(en)
*
|
1991-08-26 |
1993-01-31 |
Cytel Corp |
Hla-restricted hepatitis b virus ctl epitopes
|
US5283185A
(en)
|
1991-08-28 |
1994-02-01 |
University Of Tennessee Research Corporation |
Method for delivering nucleic acids into cells
|
IL105554A
(en)
|
1992-05-05 |
1999-08-17 |
Univ Leiden |
Peptides of human papillomavirus for use in preparations elicit a human T cell response
|
AU4528493A
(en)
|
1992-06-04 |
1994-01-04 |
Regents Of The University Of California, The |
In vivo gene therapy with intron-free sequence of interest
|
US7105574B1
(en)
|
1999-03-26 |
2006-09-12 |
Vical Incorporated |
Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines
|
US5334761A
(en)
|
1992-08-28 |
1994-08-02 |
Life Technologies, Inc. |
Cationic lipids
|
US9266930B1
(en)
|
1993-03-05 |
2016-02-23 |
Epimmune Inc. |
Inducing cellular immune responses to Plasmodium falciparum using peptide and nucleic acid compositions
|
AU702517B2
(en)
|
1993-08-06 |
1999-02-25 |
Epimmune, Inc. |
Cloning and characterization of the complete MAGE-1 gene
|
AUPM500494A0
(en)
|
1994-04-12 |
1994-05-05 |
Minister For Agriculture & Rural Affairs For The State Of New South Wales, The |
Composition for use in increasing mucosal immunity
|
FR2726764B1
(fr)
|
1994-11-14 |
1997-01-31 |
Pasteur Merieux Serums Vacc |
Adjuvant pour composition vaccinale
|
US6008202A
(en)
|
1995-01-23 |
1999-12-28 |
University Of Pittsburgh |
Stable lipid-comprising drug delivery complexes and methods for their production
|
FR2732895B1
(fr)
|
1995-04-11 |
1997-05-16 |
Pasteur Merieux Serums Vacc |
Utilisation d'un compose amphipathique cationique comme agent de transfection, comme adjuvant de vaccin, ou comme medicament
|
AU6504596A
(en)
|
1995-07-21 |
1997-02-18 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity
|
US6610321B2
(en)
|
1996-07-03 |
2003-08-26 |
University Of Pittsburgh |
Emulsion formulations for hydrophilic active agents
|
US7001614B2
(en)
|
1996-08-19 |
2006-02-21 |
The United States Of America As Represented By The Department Of Health And Human Services |
Liposome complexes for increased systemic delivery
|
US7288266B2
(en)
|
1996-08-19 |
2007-10-30 |
United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Liposome complexes for increased systemic delivery
|
US20030229040A1
(en)
|
1997-03-21 |
2003-12-11 |
Georgetown University |
Cationic liposomal delivery system and therapeutic use thereof
|
US6977074B2
(en)
|
1997-07-10 |
2005-12-20 |
Mannkind Corporation |
Method of inducing a CTL response
|
US20030022854A1
(en)
|
1998-06-25 |
2003-01-30 |
Dow Steven W. |
Vaccines using nucleic acid-lipid complexes
|
US6693086B1
(en)
|
1998-06-25 |
2004-02-17 |
National Jewish Medical And Research Center |
Systemic immune activation method using nucleic acid-lipid complexes
|
AU2870300A
(en)
|
1999-02-05 |
2000-08-25 |
Genzyme Corporation |
Use of cationic lipids to generate anti-tumor immunity
|
WO2000050006A2
(en)
|
1999-02-26 |
2000-08-31 |
Chiron Corporation |
Microemulsions with adsorbed macromoelecules and microparticles
|
ES2308069T3
(es)
|
1999-03-26 |
2008-12-01 |
Vical Incorporated |
Composiciones adyuvantes para realzar inmunorespuestas a las vacunas polinucleotido-basadas.
|
EP1173600A2
(en)
|
1999-04-20 |
2002-01-23 |
The University Of British Columbia |
Cationic peg-lipids and methods of use
|
US6852334B1
(en)
|
1999-04-20 |
2005-02-08 |
The University Of British Columbia |
Cationic peg-lipids and methods of use
|
US6649170B1
(en)
|
1999-05-12 |
2003-11-18 |
Statens Serum Institut |
Adjuvant combinations for immunization composition and vaccines
|
FR2794370B1
(fr)
|
1999-06-03 |
2003-10-17 |
Biovector Therapeutics |
Fragments proteiques polyepitopiques, leur obtention et leurs utilisations notamment en vaccination
|
JP2003502345A
(ja)
|
1999-06-10 |
2003-01-21 |
メリアル |
ペットまたはスポ−ツ用動物のためのdnaワクチン
|
CA2309313A1
(en)
|
1999-08-05 |
2001-02-05 |
Board Of Trustees Of The University Of Arkansas |
Stimulation of the immune response by human dendritic cell manipulation
|
AU785319B2
(en)
|
1999-09-16 |
2007-01-11 |
Eisai Inc. |
Nucleic acids encoding polyepitope polypeptides
|
US20030008813A1
(en)
|
1999-12-17 |
2003-01-09 |
Felgner Philip L. |
Intracellular protein delivery compositions and methods of use
|
US20010026937A1
(en)
|
2000-01-11 |
2001-10-04 |
Juha Punnonen |
Monocyte-derived dendritic cell subsets
|
JP2003533181A
(ja)
*
|
2000-02-01 |
2003-11-11 |
ジ・オースティン・リサーチ・インスティテュート |
ムチン−1誘導抗原および免疫療法におけるその使用
|
EP1355670A2
(en)
|
2000-04-20 |
2003-10-29 |
University of British Columbia |
Enhanced stabilised plasmid-lipid particle-mediated transfection using endosomal membrane destabilisers
|
AU2001297693A1
(en)
|
2000-12-08 |
2002-09-12 |
Coley Pharmaceutical Gmbh |
Cpg-like nucleic acids and methods of use thereof
|
JP2004537501A
(ja)
|
2001-02-01 |
2004-12-16 |
ボード オブ リージェンツ, ザ ユニバーシティ オブ テキサス システム |
肺への遺伝子送達のための安定化ポリマーエアロゾル
|
CA2441947C
(en)
|
2001-03-23 |
2014-05-13 |
The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Human papilloma virus immunoreactive peptides
|
FR2824326B1
(fr)
|
2001-05-04 |
2004-03-19 |
Commissariat Energie Atomique |
Melange de peptides issus des proteines e6 et/ou e7 de papillomavirus et leurs applications
|
WO2002097116A2
(en)
|
2001-05-30 |
2002-12-05 |
The Scripps Research Institute |
Delivery system for nucleic acids
|
WO2002102407A1
(en)
*
|
2001-06-15 |
2002-12-27 |
Nordic Vaccine Technology A/S |
Therapeutical vaccination
|
WO2003002142A1
(en)
|
2001-06-29 |
2003-01-09 |
Chugai Seiyaku Kabushiki Kaisha |
Cancer vaccine containing cancer antigen based on tumor suppressor gene wt1 product and cationic liposomes
|
AU2002354804A1
(en)
*
|
2001-07-06 |
2003-01-21 |
Sloan-Kettering Institute For Cancer Research |
Polyvalent conjugate vaccine for cancer
|
GB0118517D0
(en)
|
2001-07-30 |
2001-09-19 |
Mitsubishi Tokyo Pharm Inc |
Compound
|
EP2314712B1
(en)
|
2001-11-07 |
2014-01-08 |
Mannkind Corporation |
Expression vectors encoding epitopes of antigens and methods for their design
|
US7598421B2
(en)
|
2002-05-08 |
2009-10-06 |
Ucl Biomedica Plc |
Materials for the delivery of biologically-active material to cells
|
CN100340289C
(zh)
|
2002-07-05 |
2007-10-03 |
利普生技术有限公司 |
增强核酸接种免疫应答的方法
|
WO2004014957A1
(en)
|
2002-08-12 |
2004-02-19 |
The Council Of The Queensland Institute Of Medical Research |
Novel immunogenic lipopeptides comprising t-helper and cytotoxic t lymphocyte (ctl) epitopes
|
US20050031587A1
(en)
|
2002-10-04 |
2005-02-10 |
Yamanouchi Pharmaceutical Co., Ltd. |
Immune response induction method
|
ATE465753T1
(de)
|
2002-10-21 |
2010-05-15 |
Eisai Inc |
Zusammensetzungen und verfahren zurbehandlung von krankheiten, die durch das humane papillomavirus vermitteltwerden
|
SE0301109D0
(sv)
|
2003-04-14 |
2003-04-14 |
Mallen Huang |
Nucleotide vaccine composition
|
JP2007500239A
(ja)
|
2003-05-30 |
2007-01-11 |
アルザ・コーポレーシヨン |
薬剤の肺投与の方法
|
WO2005000889A1
(en)
|
2003-06-05 |
2005-01-06 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Immunogenic peptides for the treatment of prostate and breast cancer
|
EP1638610B1
(en)
|
2003-06-18 |
2015-03-18 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Sphingoid polyalkylamine conjugates for vaccination
|
US7906122B2
(en)
|
2003-06-18 |
2011-03-15 |
Yissum Research Development Company Of The Hebrew University Of Jersusalem |
Sphingoid polyalkylamine conjugates for Hepatitis B virus vaccination
|
US8592197B2
(en)
|
2003-07-11 |
2013-11-26 |
Novavax, Inc. |
Functional influenza virus-like particles (VLPs)
|
US20060182793A1
(en)
|
2003-07-22 |
2006-08-17 |
Cytos Biotechnology Ag |
Cpg-packaged liposomes
|
CA2537900A1
(en)
|
2003-09-03 |
2005-04-28 |
Dendritherapeutics, Inc. |
Multiplex vaccines
|
US20050112559A1
(en)
*
|
2003-09-29 |
2005-05-26 |
The Chinese University Of Hong Kong |
Compositions and methods for diagnosing and preventing severe acute respiratory syndrome (SARS)
|
CN1893981B
(zh)
|
2003-12-10 |
2011-03-23 |
坎基股份有限公司 |
用于治疗干扰素耐药性肿瘤的方法和组合物
|
CN1559607A
(zh)
|
2004-02-20 |
2005-01-05 |
�й�ũҵ��ѧ |
一种核酸物质与蛋白质类组合物及其生产方法和在免疫调节中的应用
|
KR20110132416A
(ko)
|
2004-04-05 |
2011-12-07 |
화이자 프로덕츠 인코포레이티드 |
미세유체화된 수중유 유화액 및 백신 조성물
|
GB0716992D0
(en)
|
2007-08-31 |
2007-10-10 |
Immune Targeting Systems Its L |
Influenza antigen delivery vectors and constructs
|
US7303881B2
(en)
|
2004-04-30 |
2007-12-04 |
Pds Biotechnology Corporation |
Antigen delivery compositions and methods of use
|
JP4764426B2
(ja)
|
2004-06-07 |
2011-09-07 |
プロチバ バイオセラピューティクス インコーポレイティッド |
カチオン性脂質および使用方法
|
CN101022827A
(zh)
*
|
2004-06-30 |
2007-08-22 |
魁北克益得生物医学公司 |
用于治疗冠状病毒感染的疫苗组合物
|
WO2006007712A1
(en)
|
2004-07-19 |
2006-01-26 |
Protiva Biotherapeutics, Inc. |
Methods comprising polyethylene glycol-lipid conjugates for delivery of therapeutic agents
|
DE102004057303A1
(de)
*
|
2004-11-26 |
2006-06-01 |
Merck Patent Gmbh |
Stabile Kristallmodifikationen von DOTAP Chlorid
|
NZ583157A
(en)
|
2004-12-13 |
2011-12-22 |
Leo Lab Ltd |
Treatment of solid cancers with angeloyl substituted ingenanes
|
JP2008535771A
(ja)
*
|
2004-12-14 |
2008-09-04 |
アプレラ コーポレイション |
カチオン性リポソームおよびその使用方法
|
CA2595704A1
(en)
|
2005-01-21 |
2006-07-27 |
Introgen Therapeutics, Inc. |
Topical administration permitting prolonged exposure of target cells to therapeutic and prophylactic nucleic acids
|
US8338366B2
(en)
|
2005-03-14 |
2012-12-25 |
The Board of Regents of the University of the Texas System |
Bioactive FUS1 peptides and nanoparticle-polypeptide complexes
|
CN101142851B
(zh)
|
2005-03-18 |
2012-12-05 |
唯听助听器公司 |
助听器的远程控制系统
|
KR20160045151A
(ko)
|
2005-04-08 |
2016-04-26 |
아르고스 쎄라퓨틱스 인코포레이티드 |
수지상 세포 조성물 및 방법
|
BRPI0609362A2
(pt)
|
2005-04-11 |
2010-03-30 |
Us Gov Health & Human Serv |
vetor de adenovìrus recombinante, adenovìrus recombinante, composição imunogênica e método para a produção da referida composição imunogênica
|
US20060275777A1
(en)
|
2005-06-03 |
2006-12-07 |
Waelti Ernst R |
Novel strategies for protein vaccines
|
US20070059318A1
(en)
|
2005-08-15 |
2007-03-15 |
Balu-Iyer Sathy V |
Lipid nano particulates containing antigens as cancer vaccines
|
US20110305713A1
(en)
|
2005-10-21 |
2011-12-15 |
Medical College Of Georgia Research Institute, Inc |
Methods and compositions to enhance vaccine efficacy by reprogramming regulatory t cells
|
ES2514316T3
(es)
|
2005-11-22 |
2014-10-28 |
Novartis Vaccines And Diagnostics, Inc. |
Partículas similares a virus (VLPs) de Norovirus y Sapovirus
|
WO2007106073A2
(en)
*
|
2006-03-02 |
2007-09-20 |
University Of Massachusetts |
Modified pathogens for use as vaccines
|
JP2007238559A
(ja)
|
2006-03-10 |
2007-09-20 |
Nagoya City Univ |
未成熟樹状細胞活性化剤及びその使用
|
BRPI0710238A2
(pt)
|
2006-04-21 |
2011-08-09 |
Transgene Sa |
uso de uma composição
|
US20080014251A1
(en)
|
2006-07-14 |
2008-01-17 |
Advanced Vascular Dynamics |
Hemostatic compound and its use
|
EP1894941A1
(en)
|
2006-09-01 |
2008-03-05 |
Institut Pasteur |
Treatment of cervical carcinoma with a recombinant adenylate cyclase carrying HPV antigens
|
EP2084267B1
(en)
|
2006-09-26 |
2018-04-11 |
Cedars-Sinai Medical Center |
Cancer stem cell antigen vaccines and methods
|
US20100099745A1
(en)
|
2006-10-18 |
2010-04-22 |
Suryaprakash Sambhara |
Enhancing disease resistance against rna viral infections with intracytoplasmic pathogen sensors
|
KR100817024B1
(ko)
|
2006-11-09 |
2008-03-26 |
재단법인 목암생명공학연구소 |
핵산 또는 약물을 간에 특이적으로 전달하는 복합체 및이를 포함하는 약학적 조성물
|
US8877206B2
(en)
*
|
2007-03-22 |
2014-11-04 |
Pds Biotechnology Corporation |
Stimulation of an immune response by cationic lipids
|
EP2167480A2
(en)
|
2007-05-23 |
2010-03-31 |
Vical Incorporated |
Cationic lipids compositions and methods for enhancing immune responses to vaccines
|
US7832751B2
(en)
*
|
2007-06-29 |
2010-11-16 |
Harley-Davidson Motor Company Group, Inc. |
Rear fender assembly
|
EA019836B1
(ru)
|
2007-11-02 |
2014-06-30 |
Те Джонс Хопкинс Юниверсити |
Композиции многотипных пептидов hpv и способы лечения или предотвращения папилломавирусной инфекции у человека
|
JP5971945B2
(ja)
|
2008-04-17 |
2016-08-17 |
ピーディーエス バイオテクノロジー コーポレイションPds Biotechnology Corporation |
カチオン性脂質の鏡像異性体による免疫応答の刺激
|
CA2724408A1
(en)
|
2008-05-19 |
2009-11-26 |
The University Of North Carolina At Chapel Hill |
Methods and compositions comprising novel cationic lipids
|
WO2010033863A2
(en)
|
2008-09-18 |
2010-03-25 |
Juvaris Biotherapeutics, Inc. |
Vaccine compositions of m2e, ha0 and bm2 multiple antigenic peptides
|
JP2012519484A
(ja)
|
2009-03-06 |
2012-08-30 |
マウント・シナイ・スクール・オヴ・メディシン |
マイクロrna応答要素を含む弱毒化生インフルエンザウイルスワクチン
|
JP5797190B2
(ja)
|
2009-05-15 |
2015-10-21 |
アイ アール エックス セーラピューティクス, インコーポレイテッド |
ワクチン免疫療法
|
WO2011109294A1
(en)
|
2010-03-01 |
2011-09-09 |
Dicerna Pharmaceuticals, Inc. |
Lipid delivery formulations
|
CN102939103A
(zh)
|
2010-03-30 |
2013-02-20 |
西奈山医学院 |
流感病毒疫苗及其应用
|
EP2567951B1
(en)
|
2010-04-28 |
2018-09-19 |
Kyowa Hakko Kirin Co., Ltd. |
Cationic lipid
|
JP2014521657A
(ja)
|
2011-07-27 |
2014-08-28 |
ベイラー リサーチ インスティテュート |
膵臓がんに対する樹状細胞(dc)ワクチン療法
|
JP6600459B2
(ja)
|
2011-09-12 |
2019-10-30 |
ピーディーエス バイオテクノロジー コーポレイション |
粒子状ワクチン製剤
|
EP2638896A1
(en)
|
2012-03-14 |
2013-09-18 |
Bioneer A/S |
Cationic liposomal drug delivery system for specific targeting of human cd14+ monocytes in whole blood
|
EP2639299A1
(en)
|
2012-03-16 |
2013-09-18 |
Invectys |
Universal cancer peptides derived from telomerase
|
JP6348489B2
(ja)
|
2012-06-15 |
2018-07-04 |
ピーディーエス バイオテクノロジー コーポレイションPds Biotechnology Corporation |
カチオン性脂質ワクチン組成物および使用方法
|
WO2014047533A1
(en)
|
2012-09-21 |
2014-03-27 |
Frank Bedu-Addo |
Improved vaccine compositions and methods of use
|
BR112016003400A2
(pt)
|
2013-08-21 |
2017-12-05 |
Curevac Ag |
composição e vacina para tratamento de câncer de pulmão
|
AU2014340201B2
(en)
|
2013-10-23 |
2019-02-21 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
HLA-A24 agonist epitopes of MUC1-C oncoprotein and compositions and methods of use
|
CN104189897A
(zh)
|
2014-05-21 |
2014-12-10 |
深圳先进技术研究院 |
一种树突状细胞高效负载抗原的制备方法
|
JP6944876B2
(ja)
|
2015-03-16 |
2021-10-06 |
マックス−デルブリュック−ツェントルム フューア モレキュラーレ メディツィン イン デア ヘルムホルツ−ゲマインシャフト |
Mhc細胞ライブラリーを用いる、新規の免疫原性t細胞エピトープの検出方法および新規の抗原特異的t細胞受容体の単離方法
|
CN105920599B
(zh)
|
2015-09-17 |
2020-02-11 |
武汉生物制品研究所有限责任公司 |
以阳离子脂质体dotap为佐剂的疫苗及其制备方法
|
WO2017083820A1
(en)
|
2015-11-13 |
2017-05-18 |
Pds Biotechnology Corporation |
Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy
|
US20180221475A1
(en)
|
2016-10-05 |
2018-08-09 |
Pds Biotechnology Corporation |
Methods to alter the tumor microenvironment for effective cancer immunotherapy
|
CA3039211A1
(en)
|
2016-10-05 |
2018-04-12 |
Pds Biotechnology Corporation |
Novel hpv16 non hla-restricted t-cell vaccines, compositions and methods of use thereof
|
EP3720423A4
(en)
|
2017-12-05 |
2021-09-08 |
PDS Biotechnology Corporation |
PROCEDURES AND COMPOSITIONS WITH CATIONIC LIPIDS FOR STIMULATING INTERFERON GENES OF TYPE 1
|
CN111217918B
(zh)
*
|
2020-03-04 |
2020-11-10 |
中山大学 |
一种基于2,4-二氧四氢喋啶合酶的新型冠状病毒s蛋白双区域亚单位纳米疫苗
|